Early results of the plasma treatment from patients were “promising enough” that physicians began offering it as a paid service outside of the clinical trial, but have since stopped because of the high demand.
While experts are unsure how effective the therapy is, there are several hypotheses as to why it may be effective, including the idea that the treatment spurs the clearance of odor molecules, which allows new molecules to attach and be detected.
Glen D’Souza, MD, the otolaryngologist at Jefferson Health, told The Philadelphia Inquirer one thing physicians are sure of is that the procedure is safe, as patients are receiving “enriched concentrations” of substances from their own bodies.
“The idea is to take advantage of whatever the body does to heal itself,” Dr. D’Souza said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
